GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NGeneBio Co Ltd (XKRX:354200) » Definitions » Gross-Profit-to-Asset %

NGeneBio Co (XKRX:354200) Gross-Profit-to-Asset % : -4.04% (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is NGeneBio Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. NGeneBio Co's annualized Gross Profit for the quarter that ended in Dec. 2024 was ₩-1,345 Mil. NGeneBio Co's average Total Assets over the quarter that ended in Dec. 2024 was ₩33,332 Mil. Therefore, NGeneBio Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 was -4.04%.


NGeneBio Co Gross-Profit-to-Asset % Historical Data

The historical data trend for NGeneBio Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NGeneBio Co Gross-Profit-to-Asset % Chart

NGeneBio Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial 2.95 5.15 8.28 -0.28 5.70

NGeneBio Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.62 3.36 11.69 12.12 -4.04

Competitive Comparison of NGeneBio Co's Gross-Profit-to-Asset %

For the Biotechnology subindustry, NGeneBio Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NGeneBio Co's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NGeneBio Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where NGeneBio Co's Gross-Profit-to-Asset % falls into.


;
;

NGeneBio Co Gross-Profit-to-Asset % Calculation

NGeneBio Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=2145.513/( (42282.281+32949.992)/ 2 )
=2145.513/37616.1365
=5.70 %

NGeneBio Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2024 )/( (Total Assets (Q: Sep. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=-1345.48/( (33714.056+32949.992)/ 2 )
=-1345.48/33332.024
=-4.04 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


NGeneBio Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of NGeneBio Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


NGeneBio Co Business Description

Traded in Other Exchanges
N/A
Address
288, Digital-ro, No. 303-307, 904ho, Guro-gu, Seoul, KOR, 08390
NGeneBio Co Ltd is engaged in the business of developing companion diagnosis, disease diagnosis, and liquid biopsy products and bioinformatics software.

NGeneBio Co Headlines

No Headlines